Metoprolol + Trimetazidine Tablet
Metoprolol + Trimetazidine Tablet
Metoprolol + Trimetazidine — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing
Form: Tablet
Class: Fixed-Dose Combination — Cardioselective beta-blocker + Metabolic anti-anginal agent
✓ Pan-India Monopoly PCD
✓ Available Now
Pricing, brochure & monopoly territory within 24 hrs.
Metoprolol + Trimetazidine Tablet is manufactured and supplied by Trumac Healthcare, a WHO-GMP certified pharmaceutical company in India. This tablet is available for monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing across all Indian states.
Therapeutic Indications
- Hypertension
- Angina and secondary prevention after heart attack
- Add-on treatment of stable angina pectoris
- Angina not adequately controlled by first-line anti-anginal drugs
Mechanism of Action
Metoprolol — Selectively blocks beta-1 receptors in the heart, lowering heart rate, contractility and blood pressure, which reduces cardiac oxygen demand.
Trimetazidine — Trimetazidine shifts heart muscle energy production from fatty acid oxidation to more oxygen-efficient glucose oxidation by inhibiting the enzyme 3-ketoacyl-CoA thiolase. This preserves cardiac energy during ischaemia without changing heart rate or blood pressure.
Combining these ingredients in one tablet provides complementary action on the target condition and simplifies therapy compared with taking the components separately.
Dosage & Administration
- Dosage of Metoprolol + Trimetazidine Tablet must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
- Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
- Do not exceed the prescribed dose, and complete the full course as advised.
- Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
- To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
- Fatigue
- Slow heart rate
- Dizziness and headache
- Nausea, vomiting or abdominal pain
- Weakness
Contraindications
- Known hypersensitivity to any component of the formulation
- Severe bradycardia, heart block or cardiogenic shock
- Asthma — use with caution
- Parkinson's disease, tremor, restless legs or other movement disorders
- Severe kidney impairment; dose reduction in moderate impairment and elderly
Storage
Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.
PCD Pharma Franchise & Third Party Manufacturing — Metoprolol + Trimetazidine Tablet
- ✓ WHO-GMP certified manufacturing — every batch QC released
- ✓ Monopoly PCD franchise rights at district or state level
- ✓ Third party / contract manufacturing under your own brand
- ✓ Wholesale and distributor supply against drug licence + GST
- ✓ Attractive net rates with healthy PTR / PTS margins
- ✓ Dispatch within 48 hours of payment realisation
Composition: Metoprolol + Trimetazidine. It is a fixed-dose combination of cardioselective beta-blocker and metabolic anti-anginal agent, used for hypertension and add-on treatment of stable angina pectoris. Trumac Healthcare supplies it with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.
Metoprolol + Trimetazidine Tablet brings together Metoprolol (cardioselective beta-blocker) and Trimetazidine (metabolic anti-anginal agent) in a single fixed-dose formulation.
PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Metoprolol + Trimetazidine Tablet under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.
Frequently Asked Questions
Who manufactures Metoprolol + Trimetazidine Tablet in India?
Trumac Healthcare is a WHO-GMP certified manufacturer and supplier of Metoprolol + Trimetazidine Tablet in India. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.
What is Metoprolol + Trimetazidine Tablet used for?
Metoprolol + Trimetazidine Tablet is used for hypertension; angina and secondary prevention after heart attack; add-on treatment of stable angina pectoris; angina not adequately controlled by first-line anti-anginal drugs. It should be used as advised by a registered medical practitioner.
Is Metoprolol + Trimetazidine Tablet available for PCD pharma franchise on monopoly basis?
Yes. Metoprolol + Trimetazidine Tablet is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.
Do you offer Metoprolol + Trimetazidine for third party or contract manufacturing?
Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Metoprolol + Trimetazidine Tablet under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.
Can Metoprolol + Trimetazidine Tablet be supplied on wholesale or distributor basis?
Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.
What is the therapeutic class of Metoprolol + Trimetazidine?
Metoprolol + Trimetazidine is a fixed-dose combination of cardioselective beta-blocker and metabolic anti-anginal agent (therapeutic class: Fixed-Dose Combination — Cardioselective beta-blocker + Metabolic anti-anginal agent).
What documentation is provided with each supply?
Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.
How quickly can an order be dispatched?
Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.
Is a prescription required for Metoprolol + Trimetazidine Tablet?
Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.
Ready to start your PCD franchise for Metoprolol + Trimetazidine Tablet?